Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Rambam Health Care Campus · Sungkyunkwan University · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
63
total citations
- FWCI
- 72.66
- Percentile
- 100%
- References
- 115
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Lung cancer
- Clinical Practice
- Cancer
- Oncology
- Intensive care medicine
- Medical physics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZenecaAward: 2013-March 2025
- GGlaxoSmithKline
- NNovartis
- RRoche
- SSanofi
- GSGilead Sciences
- IAInternational Association for the Study of Lung Cancer
- TPTeva Pharmaceutical Industries
- FHF. Hoffmann-La Roche
- ABArray BioPharma
- VMVarian Medical Systems
- RPRegeneron Pharmaceuticals
- NNovocure
- LLLes Laboratories Pierre Fabre
- BBeiGene
- IIncyte
- AApollomics
- ESEuropean School of Oncology
- EEisai
- ESEuropean Society for Medical Oncology
- SESociedad Española de Oncología Médica
- PPharmaMar
- NPNordic Pharma Group
- GGenentech
- CPChugai Pharmaceutical
- IIgnyta
- FMFoundation Medicine
- DSDaiichi Sankyo Europe